Alembic Share Price

    NSE
    117.05
    -1.53 (0.85%)
    ALEMBICLTD • 08 Jul, 2025 | 01:05 PM
    BUY

    1Y Annualised Return

    -9.23%

    3Y Annualised Return

    17.20%

    5Y Annualised Return

    7.82%

    The current prices are delayed, login or Open Demat Account for live prices.

    Alembic Stock Performance

    1W Return-5.04
    1Y Return-10.57
    Today's Low116.28
    Prev. Close118.58
    Mkt Cap (Cr.)3,044.92
    1M Return4.25
    3Y Return59.39
    52-Week High169
    Open118.40
    PE Ratio21.48
    6M Return-11.24
    Today's High119.8
    52-Week Low85.46
    Face Value2

    Alembic Company background

    Founded in: 1907
    Managing director: Malika C Amin
    Alembic Limited is one of the Indias most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in the manufacture of Bulk Drugs and Real Estate Business. The company manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. It works manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.Alembic Limited was incorporated in year 1907 with the name Alembic Chemical Works Company Limited in Vadodara to manufacture tinctures and alcohol. The name of the Company was changed to Alembic Limited in August, 1999. The Company started to manufacture cough syrup, vitamins, tonics and sulphur durgs in 1940. In 1961, it inaugurated the Pencillin Palnt. In 1968, it started to manufacture Streptomycin.In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In June 2001, the company formed a wholly owned subsidiary company named Alembic Europe Pvt Ltd in UK.In the year 2005, the company has launched ZERO, a new generation, no calories, Sucralose Based Sugar Substitute which gave entry for the company into the highgrowth lifestyle OTC product segment. In May 2005, the generic alliances and API division were merged to form an independent SBU.The company has set up a formulation manufacturing facility at Baddi in Himachal Pradesh with a production capacity 900 million tablets and 600 million liquid oral bottles annually. During the year 200506, the company has increased the installed capacity of Tablets Capsules and Oral Preparation Ointments by 595 Million Nos and 720 MT respectively.During the year 200506, the company acquired API Plant at Karakhadi in Vadodara. In the year 2007, the company acquired the NonOncology Business of Dabur Pharma Ltd. Also in the same year, they entered into a licensing agreement for its Novel Drug Delivery Platform for Keppra XR with UCB Belgium. During the year 200708, the company acquired the API manufacturing facility of Nirayu Pvt Ltd at Panelav near Vododara.The Company formed a wholly owned subsidiary viz. Alembic Global Holding SA in Neuchatel, Switzerland in 2009. The Pharmaceutical Undertaking of the Company demerged and the same got transferred to Alembic Pharmaceuticals Limited with effect from Appointed date i.e. 1st April, 2010. The maiden real estate project Samsara was completed in 2014. The Company launched second real estate project, VEDA in 201516. It further launched two APIs in 2017. During year 201718, Alembic City Limited (formerly known as Alembic Exports Limited) became whollyowned subsidiary of the Company.During 201819, the Composite Scheme of Arrangement comprising of transfer and vesting of the Identified Real Estate Undertaking of Alembic Limited (the Company / the First Demerged Company) into Shreno Limited (the First Transferee Company/ the Second Demerged Company) and transfer and vesting of Engineering Division and Investment Division of Shreno Limited into Nirayu Private Limited (the Second Transferee Company) and their respective shareholders with effect from the Appointed Date i.e. 1st November, 2018 was sanctioned by the Honble National Company Law Tribunal, Ahmedabad Bench (NCLT) vide its order dated 26th July, 2019. Accordingly, Scheme was made effective from 26th July, 2019.The Company launched a residential project VEDA II during 2020. In FY 2025, VEDAII, one of the Companys gated community project has been completed in FY 2025. The Companys upscale premium residential projects, Townhouse24 also achieved 100% sales during the year. Other premium projects like The Villas and The Gardens witnessed decent demand. The Company also launched another housing project with 3BHK and 4BHK configurations called The Park Crescent.

    As of 08 Jul, 2025, Alembic share price is ₹116.8. The stock opened at ₹118.4 and had closed at ₹118.6 the previous day. During today’s trading session, Alembic share price moved between ₹116.28 and ₹119.80, with an average price for the day of ₹118.04. Over the last 52 weeks, the stock has recorded a low of ₹85.46 and a high of ₹169.00. In terms of performance, Alembic share price has declined by 12.9% over the past six months and has declined by 9.23% over the last year.

    Read More
    Alembic SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹62,07,892 (-4.49%)

    Daily SIP of 25,000 would have become 62,07,892 in 1 year with a gain of -2,92,107 (-4.49%)

    View details of Market Depth

    Alembic Fundamental

    Market Cap (in crs)

    3,044.92

    Face Value

    2

    Turnover (in lacs)

    337.38

    Key Metrics

    Qtr Change %
    30.87% Fall from 52W High
    20.6
    Dividend yield 1yr %
    High in industry
    2.1

    Alembic Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Alembic Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    60.27 Cr
    57.92 Cr
    52.91 Cr
    50.78 Cr
    49.04 Cr
    Alembic Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    296.78 Cr
    212.26 Cr
    191.51 Cr
    167.4 Cr
    83.79 Cr
    167.33 Cr
    Alembic Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    23.75 Cr
    26.09 Cr
    77.31 Cr
    17.42 Cr
    21.29 Cr
    Alembic Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    144.57 Cr
    92.87 Cr
    80.62 Cr
    86.19 Cr
    13.84 Cr
    93.03 Cr

    Alembic Result Highlights

    • Alembic Ltd reported a 18.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 30.4%.

    • Its expenses for the quarter were down by 23.0% QoQ and up 5.3% YoY.

    • The net profit increased 10.3% QoQ and increased 49.5% YoY.

    • The earnings per share (EPS) of Alembic Ltd stood at 2.8 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Alembic

    Promoter
    70.9%
    Foreign Institutions
    1.6%
    Domestic Institutions
    0.1%
    Public
    27.4%
    Promoter
    70.9%
    Foreign Institutions
    1.8%
    Public
    27.3%
    Promoter
    70.9%
    Foreign Institutions
    2%
    Domestic Institutions
    0.1%
    Public
    27.1%
    Promoter
    70.9%
    Foreign Institutions
    1.4%
    Domestic Institutions
    0.1%
    Public
    27.6%
    Promoter
    70.9%
    Foreign Institutions
    1.1%
    Public
    28%
    Promoter
    70.9%
    Foreign Institutions
    0.9%
    Public
    28.2%

    Alembic Technical Analysis

    Moving Averages Analysis
    117.05
    Current Price
    Bullish Moving Averages
    10
    Bearish Moving Averages
    6
    5Day EMA
    119.30
    10Day EMA
    118.20
    12Day EMA
    117.80
    20Day EMA
    116.30
    26Day EMA
    115.30
    50Day EMA
    112.30
    100Day EMA
    111.60
    200Day EMA
    113.40
    5Day SMA
    120.40
    10Day SMA
    118.10
    20Day SMA
    116.20
    30Day SMA
    114.60
    50Day SMA
    110.70
    100Day SMA
    105.20
    150Day SMA
    113.20
    200Day SMA
    118.20
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    178466 Rs
    375696 Rs
    Week Rs
    247076 Rs
    652454 Rs
    Month Rs
    362901 Rs
    1153520 Rs
    119.40
    Pivot
    Resistance
    First Resistance
    120.61
    Second Resistance
    122.63
    Third Resistance
    123.84
    Support
    First Support
    117.38
    Second support
    116.17
    Third Support
    114.15
    Relative Strength Index
    57.62
    Money Flow Index
    75.07
    MACD
    2.53
    MACD Signal
    2.30
    Average True Range
    3.60
    Average Directional Index
    28.64
    Rate of Change (21)
    5.81
    Rate of Change (125)
    -12.95

    Alembic Latest News

    07 JUL 2025 | Monday

    Alembic Ltd - 506235 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    07 JUL 2025 | Monday

    Alembic Ltd - 506235 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

    05 JUL 2025 | Saturday

    Alembic Ltd - 506235 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    View More

    Alembic Share Price FAQs

    Alembic share price is ₹117.05 in NSE and ₹117.1 in BSE as on 8/7/2025.

    Alembic share price in the past 1-year return was -10.57. The Alembic share hit a 1-year low of Rs. 85.46 and a 1-year high of Rs. 169.

    The market cap of Alembic is Rs. 3044.92 Cr. as of 8/7/2025.

    The PE ratios of Alembic is 21.48 as of 8/7/2025.

    The PB ratios of Alembic is 3.57 as of 8/7/2025

    You can easily buy Alembic shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Alembic share price is ₹169 and ₹85.46 as of 8/7/2025.

    Please be aware that Alembic stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    66.12
    +0.24 (+0.36%)
    137.45
    -1.09 (-0.79%)
    691.25
    +2.40 (+0.35%)
    2,583.00
    +6.90 (+0.27%)
    165.92
    -1.21 (-0.72%)
    385.35
    -4.10 (-1.05%)
    162.23
    -0.17 (-0.10%)
    262.25
    +3.70 (+1.43%)
    421.35
    +4.25 (+1.02%)
    399.35
    -1.85 (-0.46%)
    Top Gainers
    2,220.00
    +70.20 (+3.27%)
    2,830.70
    +51.60 (+1.86%)
    262.60
    +4.05 (+1.57%)
    12,495.00
    +150.00 (+1.22%)
    1,645.80
    +18.80 (+1.16%)
    Top Losers
    3,459.90
    -206.20 (-5.62%)
    1,281.40
    -29.10 (-2.22%)
    8,320.50
    -143.00 (-1.69%)
    5,407.50
    -91.50 (-1.66%)
    1,488.40
    -22.10 (-1.46%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -